ESMA shall carry out assessments of the resilience of recognised CCPs to adverse market developments in accordance with Article 32(2) of Regulation (EU) No 1095/2010.
ESMA izvede oceno odpornosti priznane CNS na neugodne razvoje na trgu v skladu s členom 32(2) Uredbe (EU) št. 1095/2010.